The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers.
Name:
journal.pone.0206007 (1).pdf
Size:
2.013Mb
Format:
PDF
Description:
Full text open access article
Authors
Lamarca, AngelaGaldy, Salvatore
Barriuso, Jorge
Moghadam, Sharzad
Beckett, Elizabeth
Rogan, Jane
Backen, Alison C
Billington, Catherine
McNamara, Mairéad G
Hubner, Richard A
Cramer, Angela
Valle, Juan W
Affiliation
Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United KingdomIssue Date
2018
Metadata
Show full item recordAbstract
Expression of human epidermal growth factor receptor (HER)2 and HER3 have been investigated in small BTC studies using variable scoring systems.Citation
The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers. 2018, 13 (10):e0206007 PLoS ONEJournal
PLoS ONEDOI
10.1371/journal.pone.0206007PubMed ID
30335866Type
ArticleLanguage
enISSN
1932-6203ae974a485f413a2113503eed53cd6c53
10.1371/journal.pone.0206007
Scopus Count
Collections
Related articles
- Overexpression and gene amplification of EGFR, HER2, and HER3 in biliary tract carcinomas, and the possibility for therapy with the HER2-targeting antibody pertuzumab.
- Authors: Kawamoto T, Ishige K, Thomas M, Yamashita-Kashima Y, Shu S, Ishikura N, Ariizumi S, Yamamoto M, Kurosaki K, Shoda J
- Issue date: 2015 Apr
- HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?
- Authors: Galdy S, Lamarca A, McNamara MG, Hubner RA, Cella CA, Fazio N, Valle JW
- Issue date: 2017 Mar
- Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients.
- Authors: Berghoff AS, Bartsch R, Preusser M, Ricken G, Steger GG, Bago-Horvath Z, Rudas M, Streubel B, Dubsky P, Gnant M, Fitzal F, Zielinski CC, Birner P
- Issue date: 2014 Oct
- Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
- Authors: Begnami MD, Fukuda E, Fregnani JH, Nonogaki S, Montagnini AL, da Costa WL Jr, Soares FA
- Issue date: 2011 Aug 1
- Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4-1 and NRDP1, in primary breast cancer.
- Authors: Luhtala S, Staff S, Kallioniemi A, Tanner M, Isola J
- Issue date: 2018 Oct 26